Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia.


OBJECTIVE We assessed the association of glycosylated fibronectin (GlyFn) with preeclampsia and its performance in a point-of-care (POC) test. STUDY DESIGN GlyFn, placental growth factor (PlGF), and soluble vascular endothelial growth factor receptor 1 (sFlt1) levels were determined in serum samples from 107 pregnant women. In all, 45 were normotensive… (More)
DOI: 10.1016/j.ajog.2014.07.052


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.